Cancer Treatment: Adding Epratuzumab To Standard Chemotherapy Looks Promising
Friday, May 16, 2008 - 10:21
in Health & Medicine
Adding a second monoclonal antibody drug to chemotherapy looks promising for treatment of diffuse large B-cell lymphoma, according to researchers working with the North Central Cancer Treatment Group.
Read the whole article on Science Daily
More from Science Daily
Related
- Adding epratuzumab to standard therapyFri, 16 May 2008, 11:22:04 EDT
- Two targeted therapies likely better than one in patients with aggressive lymphomaFri, 15 May 2009, 9:16:39 EDT
- Experimental chemotherapy regimen shows promise in treating advanced lung cancerTue, 12 Aug 2008, 6:14:50 EDT
- JNCI news brief: Antibody linked to chemotherapy drug inhibits ovarian cancer in labWed, 29 Jul 2009, 17:39:03 EDT
- New treatment shows promise against recurrent gynecologic cancersTue, 21 Apr 2009, 18:49:39 EDT